Entrada Therapeutics, Inc. Common Stock — Grafico, Quotazione e Notizie (NASDAQ:TRDA) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Market Capitalization 544.4029 M
Employee 152
Founded 2016
CEO N/A
Website www.entradatx.com
Headquarter Delaware, United States
FIGI BBG00MTSMC16
Industry Technology

Ricavi totali

Utile netto

Utile base per azione (EPS base)

Debito totale

Liquidità libera

Disponibilità liquide e mezzi equivalenti

544.4 M Capitalizzazione di mercato

Rapporto prezzo/utili

-2.96

Rapporto prezzo/fatturato

16.73

Notizie

Gli EPS di Entrada Therapeutics hanno battuto le aspettative per 0,04$, il fatturato appena sotto le previsioni

Entrada Therapeutics earnings beat by $0.04, revenue fell short of estimates

Arcutis Biotherapeutics, Inc. (ARQT) Surpasses Q4 Earnings and Revenue Estimates

Repligen (RGEN) Tops Q4 Earnings and Revenue Estimates

Earnings Preview: Entrada Therapeutics, Inc. (TRDA) Q4 Earnings Expected to Decline

EyePoint (EYPT) Surges 15.2%: Is This an Indication of Further Gains?

Illumina (ILMN) Tops Q4 Earnings and Revenue Estimates

Techne (TECH) Beats Q2 Earnings and Revenue Estimates

Entrada Therapeutics, Inc. (TRDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Capricor Therapeutics Stock: A High Risk/High Reward Name (NASDAQ:CAPR)

Entrada riporta progressi sui trattamenti DMD e condivide il calendario clinico

Entrada reports progress on DMD treatments, shares clinical timeline